Home > Insider Trading > Filing (0001179110-15-013306)

Filing Details

Accession Number:: 0001179110-15-013306
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-09-11 17:28:15
Reporting Period:: 2015-09-09

Filing Date:: 2015-09-11
Accepted Time:: 2015-09-11 17:28:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1042074	Cymabay Therapeutics Inc.	CBAY	Pharmaceutical Preparations (2834)	943103561

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1110780	Carl Goldfischer	C/O Cymabay Therapeutics, Inc. 7999 Gateway Blvd, Suite 130 Newark CA 94560		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-09-09	13	$2.76	28	No	4	S	Indirect	By Bay City Capital LLC
Common Stock	Disposition	2015-09-09	13,844	$2.76	29,980	No	4	S	Indirect	By The Bay City Capital Fund II, L.P.
Common Stock	Disposition	2015-09-09	905	$2.76	1,959	No	4	S	Indirect	By The Bay City Capital Fund II Co-Investment Fund, L.P
Common Stock	Disposition	2015-09-10	15	$2.71	13	No	4	S	Indirect	By Bay City Capital LLC
Common Stock	Disposition	2015-09-10	15,474	$2.71	14,506	No	4	S	Indirect	By The Bay City Capital Fund II, L.P.
Common Stock	Disposition	2015-09-10	1,011	$2.71	948	No	4	S	Indirect	By The Bay City Capital Fund II Co-Investment Fund, L.P.
Common Stock	Disposition	2015-09-11	13	$2.77	0	No	4	S	Indirect	By Bay City Capital LLC
Common Stock	Disposition	2015-09-11	14,506	$2.76	0	No	4	S	Indirect	By The Bay City Capital Fund II, L.P.
Common Stock	Disposition	2015-09-11	948	$2.76	0	No	4	S	Indirect	By The Bay City Capital Fund II Co-Investment Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Bay City Capital LLC
No	4	S	Indirect	By The Bay City Capital Fund II, L.P.
No	4	S	Indirect	By The Bay City Capital Fund II Co-Investment Fund, L.P
No	4	S	Indirect	By Bay City Capital LLC
No	4	S	Indirect	By The Bay City Capital Fund II, L.P.
No	4	S	Indirect	By The Bay City Capital Fund II Co-Investment Fund, L.P.
No	4	S	Indirect	By Bay City Capital LLC
No	4	S	Indirect	By The Bay City Capital Fund II, L.P.
No	4	S	Indirect	By The Bay City Capital Fund II Co-Investment Fund, L.P.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The Reporting Person is a managing director of Bay City Capital LLC, The Bay City Capital Fund II, L.P. and The Bay City Capital Fund II Co-Investment Fund, L.P (collectively the "Bay City Capital Funds"), and has voting and investment control over the shares owned by the Bay City Capital Funds. The Reporting Person disclaims beneficial ownership of the shares owned by the Bay City Capital Funds except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.66 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.69 to $2.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.64 to $2.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.